NWBO - Northwest Biotherapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.03B

Cash

1.424M

Avg Qtr Burn

-11.93M

Short % of Float

1.36%

Insider Ownership

11.04%

Institutional Own.

0.31%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
DCVax-L (personalized immune therapy) Details Glioblastoma	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.